154 related articles for article (PubMed ID: 38520026)
1. Prognostic PET [
Chiu KWH; Tan KV; Yang X; Zhu X; Shi J; Chiang CL; Chan L; Hui Y; Khong PL; Man K; Wong JWH
Cancer Imaging; 2024 Mar; 24(1):42. PubMed ID: 38520026
[TBL] [Abstract][Full Text] [Related]
2. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.
Park S; Kim TS; Kang SH; Kim HB; Park JW; Kim SK
Medicine (Baltimore); 2018 Sep; 97(37):e12311. PubMed ID: 30212970
[TBL] [Abstract][Full Text] [Related]
3. Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
Cheung TT; Chan SC; Ho CL; Chok KS; Chan AC; Sharr WW; Ng KK; Poon RT; Lo CM; Fan ST
Liver Transpl; 2011 Oct; 17(10):1218-25. PubMed ID: 21688383
[TBL] [Abstract][Full Text] [Related]
4. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced modulation of glucose transporter expression impacts
Xia H; Chen J; Gao H; Kong SN; Deivasigamani A; Shi M; Xie T; Hui KM
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):787-797. PubMed ID: 31832727
[TBL] [Abstract][Full Text] [Related]
6.
Na SJ; Oh JK; Hyun SH; Lee JW; Hong IK; Song BI; Kim TS; Eo JS; Lee SW; Yoo IR; Chung YA; Yun M
J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma.
Tan KV; Yang X; Chan CY; Shi J; Chang HC; Chiu KW; Man K
J Vis Exp; 2022 Aug; (186):. PubMed ID: 36121278
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.
Hyun SH; Eo JS; Lee JW; Choi JY; Lee KH; Na SJ; Hong IK; Oh JK; Chung YA; Song BI; Kim TS; Kim KS; Moon DH; Yun M
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1638-45. PubMed ID: 26936852
[TBL] [Abstract][Full Text] [Related]
9. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma.
Lee M; Ko H; Yun M
Yonsei Med J; 2018 Dec; 59(10):1143-1149. PubMed ID: 30450847
[TBL] [Abstract][Full Text] [Related]
10. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
Ho CL; Yu SC; Yeung DW
J Nucl Med; 2003 Feb; 44(2):213-21. PubMed ID: 12571212
[TBL] [Abstract][Full Text] [Related]
11. Utility of Early Posttreatment PET/CT Evaluation Using FDG or
Reizine E; Chalaye J; Mule S; Regnault H; Perrin C; Calderaro J; Laurent A; Amaddeo G; Kobeiter H; Tacher V; Itti E; Luciani A
AJR Am J Roentgenol; 2022 Feb; 218(2):359-369. PubMed ID: 34494448
[No Abstract] [Full Text] [Related]
12. Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.
Territo PR; Maluccio M; Riley AA; McCarthy BP; Fletcher J; Tann M; Saxena R; Skill NJ
BMC Med Imaging; 2015 May; 15():15. PubMed ID: 25981587
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of parameters from pretreatment (18)F-FDG PET in hepatocellular carcinoma: a meta-analysis.
Sun DW; An L; Wei F; Mu L; Shi XJ; Wang CL; Zhao ZW; Li TF; Lv GY
Abdom Radiol (NY); 2016 Jan; 41(1):33-41. PubMed ID: 26830609
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
[TBL] [Abstract][Full Text] [Related]
16. PET/CT characteristics of isolated bone metastases in hepatocellular carcinoma.
Ho CL; Chen S; Cheng TK; Leung YL
Radiology; 2011 Feb; 258(2):515-23. PubMed ID: 21062922
[TBL] [Abstract][Full Text] [Related]
17. The value of [
Li S; Peck-Radosavljevic M; Ubl P; Wadsak W; Mitterhauser M; Rainer E; Pinter M; Wang H; Nanoff C; Kaczirek K; Haug A; Hacker M
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1732-1741. PubMed ID: 28555333
[TBL] [Abstract][Full Text] [Related]
18. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
19. Utility of [
Kavanaugh G; Williams J; Morris AS; Nickels ML; Walker R; Koglin N; Stephens AW; Washington MK; Geevarghese SK; Liu Q; Ayers D; Shyr Y; Manning HC
Mol Imaging Biol; 2016 Dec; 18(6):924-934. PubMed ID: 27677886
[TBL] [Abstract][Full Text] [Related]
20. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]